Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding PBE?
Track your performance easily
PBE Price & Analysis
PBE ETF Chart & Stats
Day’s Range― - ―
52-Week Range$56.21 - $72.84
Previous Close$66.59
VolumeN/A
Average Volume (3M)6.22K
AUM258.52M
NAV66.12
Expense Ratio0.58%
Holdings Count32
Beta1.07
Inception DateJun 23, 2005
Last Dividend Ex-Date
Jun 24, 2024Dividend Yield
0.03 (0.05%)Shares Outstanding3,750,000
Standard Deviation0.06
10 Day Avg. Volume8,552
30 Day Avg. Volume6,220
Alpha-0.00299
Invesco Dynamic Biotechnology & Genome ETF (PBE) Fund Flow Chart
Invesco Dynamic Biotechnology & Genome ETF (PBE) 1 year Net Flows: -$11M
PBE ETF News
PremiumCompany Announcements
Xencor Reports Q3 2024 Earnings and Program Updates
PBE ETF FAQ
What was PBE’s price range in the past 12 months?
PBE lowest ETF price was $56.20 and its highest was $72.84 in the past 12 months.
What is the AUM of PBE?
As of Nov 15, 2024 The AUM of PBE is 258.52M.
Is PBE overvalued?
According to Wall Street analysts PBE’s price is currently Undervalued.
Does PBE pay dividends?
PBE pays a Annually dividend of <$0.01 which represents an annual dividend yield of 0.05%. See more information on PBE dividends here
How many shares outstanding does PBE have?
PBE has 3,750,000 shares outstanding.
Which hedge fund is a major shareholder of PBE?
Currently, no hedge funds are holding shares in PBE
PBE ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
United Therapeutics Corp.
5.58%
Illumina
5.42%
Amgen Inc
4.63%
Alnylam Pharmaceuticals
4.50%
Biogen Inc.
4.21%
Neurocrine Biosciences
4.18%
Xencor Inc.
4.00%
Exelixis
3.97%
TG Therapeutics
3.79%
Natera Inc.
3.77%
Total44.05%
ETF Description
Invesco Dynamic Biotechnology & Genome ETF
PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.